Crossmark

SAG-UPS attenuates proapoptotic SARM and Noxa to confer survival advantage to early hepatocellular carcinoma

Published Online: 2015-09-28

Authors

Chang, S C

Choo, W Q W

Toh, H C

Ding, J L
License Information

Text and Data Mining valid from 2015-09-28

Version of Record valid from 2015-09-28
More Information

Article History

Received: 21 July 2015

Revised: 12 August 2015

Accepted: 13 August 2015

First Online: 28 September 2015

Competing interests

: The authors declare no conflict of interest.

Document is current